Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001209191-21-023869

Director bought 15,625 shares at $16.00 ($250,000)

  • Director acquired 3,473,543 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

ROOT JONATHAN D · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-30 Conversion : show line 1 in the form +3,473,543 3,473,543 I
2021-03-30 Purchase : show line 2 in the form +15,625 $16.00 $250,000 15,625 D
Open-market purchases · 15,625 sh · avg $16.00 · $250,000

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-03-30 Conversion : show line 3 in the form Series B-1 Preferred Stock −1,651,607 0 I
2021-03-30 Conversion : show line 4 in the form Series B-2 Preferred Stock −1,366,707 0 I
2021-03-30 Conversion : show line 5 in the form Series C Preferred Stock −455,229 0 I
Loading xslF345X03/doc4.xml…